Foghorn Therapeutics (FHTX) Price to Sales (2020 - 2026)
Foghorn Therapeutics' (FHTX) Price to Sales stood at 7.80 in Q2 2026, down 28.1% from 10.85 a year earlier and down 21.6% from the prior quarter.
Analysis
Foghorn Therapeutics (FHTX) Price to Sales (2020 - 2026) Analysis & Trends
For FY2025, Foghorn Therapeutics' Price to Sales came in at 9.90, down 14.7% from FY2024.
- Across earlier years, Price to Sales came in at 11.61 in FY2024 (+45.4%), 7.98 in FY2023 (-42.4%), 13.87 in FY2022 (-98.1%) and 716.09 in FY2021 (+37.5%).
- The Q2 2026 figure is the lowest quarterly Price to Sales since Q3 2023.
- On a year-over-year basis, Price to Sales rose in five of the last eight quarters, with growth averaging 26.1%.
- Peak year-over-year performance for Price to Sales in the last five years was growth of 213.0% in Q3 2024, against a decline of 98.1% in Q4 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at 9.94 (Q1 2026), 9.90 (Q4 2025) and 11.28 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Foghorn Therapeutics | 209.61 Mn | -116.34 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.80 |
| Mar 31, 2026 | 9.94 |
| Dec 31, 2025 | 9.90 |
| Sep 30, 2025 | 11.28 |
| Jun 30, 2025 | 10.85 |
| Mar 31, 2025 | 8.65 |
| Dec 31, 2024 | 11.61 |
| Sep 30, 2024 | 20.29 |
| Jun 30, 2024 | 9.04 |
| Mar 31, 2024 | 8.43 |
| Dec 31, 2023 | 7.98 |
| Sep 30, 2023 | 6.48 |
| Jun 30, 2023 | 13.56 |
| Mar 31, 2023 | 12.58 |
| Dec 31, 2022 | 13.87 |
| Sep 30, 2022 | 22.76 |
| Jun 30, 2022 | 61.78 |
| Mar 31, 2022 | 127.39 |
| Dec 31, 2021 | 716.09 |
| Sep 30, 2021 | 602.14 |
API Access
Foghorn Therapeutics Price to Sales API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-sales&ticker=FHTX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-sales", "ticker": "FHTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=price-to-sales&ticker=FHTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();